Home/Zywie/Robert F. Johnston
RF

Robert F. Johnston

Chairman of the Board and CEO

Zywie

Zywie Pipeline

DrugIndicationPhase
Modified Ambroxol DerivativesLysosomal Storage Diseases (e.g., Gaucher disease) & related neurodegenerative disordersPre-clinical